Combined treatment with naringin and osthole ameliorates colitis through microbiota-amino acid metabolism and the JNK pathway
{{output}}
Inflammatory bowel disease (IBD), particularly ulcerative colitis, involves disruption of the intestinal mucosal barrier due to ecological and metabolic imbalances in the gut as its underlying pathology. Current therapies for Ulcerative colitis (UC) exhibit li... ...
